Galectin Therapeutics Inc. · DUS:PHPN

Galectin Therapeutics Inc. financial statements

Galectin Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue0000000000
Cost of revenue37.0K33.0K32.0K41.0K36.0K35.0K1.00K1.00K7.00K
Gross profit-37.0K-33.0K-32.0K-41.0K-36.0K-35.0K-1.00K-1.00K-7.00K
Research and development14.3M36.6M32.1M31.7M23.8M18.0M7.47M6.47M11.7M15.3M
Selling, general and administrative5.79M5.86M5.94M6.62M6.36M5.47M5.97M7.13M4.53M6.16M
Operating income-20.1M-42.4M-38.1M-38.4M-30.2M-23.4M-13.4M-13.6M-16.2M-21.5M
Depreciation and amortization53.0K00000001.00K7.00K
EBITDA-20.0M-42.4M-38.1M-38.4M-30.2M-23.4M-13.4M-13.6M-16.2M-21.5M
Interest expense7.33M5.54M2.79M1.03M489.0K87.0K87.0K336.0K12.0K0
Income before tax-30.8M-47.0M-41.1M-38.8M-30.5M-23.5M-13.3M-13.9M-16.2M-21.4M
Income tax00-2.99M424.0K448.0K51.0K87.0K024.0K0
Net income-30.8M-47.0M-41.1M-38.8M-30.5M-23.5M-13.3M-13.9M-16.2M-21.4M
Earnings per share, basic-0.48-0.76-0.74-0.65-0.52-0.41-0.39-0.38-0.49-0.76
Earnings per share, diluted-0.48-0.76-0.74-0.65-0.52-0.41-0.39-0.38-0.49-0.76

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents17.7M15.1M25.7M18.6M39.6M27.1M47.5M8.25M3.05M15.4M
Short-term investments00
Inventory00
Current assets19.4M17.3M27.7M20.6M41.8M29.5M48.2M8.83M3.82M15.8M
Property, plant and equipment0000000000
Goodwill01.00K
Total assets19.5M17.5M28.2M21.3M41.8M29.6M48.5M9.01M4.16M15.8M
Accounts payable3.25M5.66M6.43M3.89M1.80M1.29M1.66M297.0K608.0K910.0K
Current liabilities8.03M35.4M15.7M13.0M9.03M5.40M2.82M2.11M2.97M3.78M
Long-term debt133.7M85.1M71.7M39.8M29.0M00
Total debt133.8M106.2M71.8M39.9M29.1M44.0K39.0K
Total liabilities145.7M120.6M88.4M53.5M39.2M5.41M2.87M2.11M2.97M3.78M
Shareholders' equity-127.9M-104.8M-62.0M-33.9M893.0K22.5M43.9M5.17M-530.0K10.3M
Shares outstanding65.2M63.2M61.9M59.4M59.3M57.1M56.9M41.2M35.8M32.9M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-23.9M-41.8M-33.0M-31.1M-24.3M-20.6M-10.8M-10.2M-15.9M-16.4M
Capital spending0000000000
Free cash flow-23.9M-41.8M-33.0M-31.1M-24.3M-20.6M-10.8M-10.2M-15.9M-16.4M
Cash from investing000000000
Cash from financing26.5M31.2M40.0M10.0M36.8M263.0K50.1M15.4M3.58M5.92M
Dividends paid-138.0K-91.0K-120.0K-97.0K-171.0K-137.0K-394.0K-915.0K-1.23M-741.0K
Share buybacks667.0K845.0K671.0K899.0K-30.0M263.0K50.5M15.4M696.0K5.92M
Change in cash2.60M-10.5M7.07M-21.1M12.5M-20.3M39.2M5.20M-12.3M-10.5M